Related Experiment Video

Updated: Aug 22, 2026

An Adoptive Transfer Model of Rheumatoid Arthritis in Mice
07:37

An Adoptive Transfer Model of Rheumatoid Arthritis in Mice

Published on: June 6, 2025

Targeting cytokines beyond tumor necrosis factor-alpha and interleukin-1 in rheumatoid arthritis

Iain B McInnes1, J Alastair Gracie

  • 1Centre for Rheumatic Diseases, Glasgow Royal Infirmary, 10 Alexandra Parade, Glasgow, G31 2ER, Scotland. i.b.mcinnes@clinmed.gla.ac.uk

Current Rheumatology Reports
|September 10, 2004
PubMed

Insights

New research explores alternative treatments for rheumatoid arthritis beyond tumor necrosis factor-alpha (TNF-a) inhibitors. Interleukin (IL) cytokines show promise for patients unresponsive to current therapies, potentially offering new treatment avenues.

Area of Science:

  • Rheumatology
  • Immunology
  • Inflammation

Background:

  • Tumor necrosis factor-alpha (TNF-a) targeting is effective for rheumatoid arthritis (RA) but leaves many patients with unmet needs.
  • A significant portion of RA patients do not respond adequately to anti-TNF-a therapies, highlighting the need for alternative treatments.

Purpose of the Study:

  • To review emerging data on the therapeutic potential of specific pro-inflammatory cytokines in rheumatoid arthritis synovitis.
  • To evaluate cytokines such as interleukin (IL)-6, IL-12, IL-15, and IL-18 as novel treatment targets for RA.

Main Methods:

  • Literature review of recent scientific data and clinical studies.
  • Analysis of the role of specific cytokines in RA pathogenesis and their potential as therapeutic targets.

Main Results:

  • Several cytokines, including IL-6, IL-12, IL-15, and IL-18, exhibit pro-inflammatory activity in RA synovitis.
  • These cytokines represent potential therapeutic targets for RA management.

Conclusions:

  • Interleukin cytokines offer promising therapeutic potential for rheumatoid arthritis patients.
  • These cytokines may be beneficial for patients with partial response to anti-TNF-a agents or used in combination therapy.

Related Concept Videos

T Cell Types and Functions01:24

T Cell Types and Functions

When T cells with CD4 markers are activated, they give rise to two types of effector cells: helper T cells and regulatory T cells. Meanwhile, T cells with CD8 markers differentiate into effector cytotoxic T cells. The differentiation of CD4 T cells into helper T cell subsets, such as Th1, Th2, and Th17 cells, is dependent on the antigen type, antigen-presenting cell, and regulatory cytokines.
Th1 cells stimulate dendritic cells to express necessary co-stimulatory molecules on their surfaces for...
Drugs for Treatment of Crohn's Disease in IBD Using Biologic Agents: Anti-TNF01:24

Drugs for Treatment of Crohn's Disease in IBD Using Biologic Agents: Anti-TNF

Tumor Necrosis Factor (TNF), a proinflammatory cytokine, contributes significantly to the inflammation seen in Crohn's disease. It exists as soluble TNF and membrane-bound TNF, with actions mediated through TNF receptors (TNFR). TNFR activation leads to the release of proinflammatory cytokines, T-cell activation, collagen production, and leukocyte migration, all contributing to inflammation in Crohn's disease. Anti-TNF monoclonal antibodies, namely infliximab (Remicade), adalimumab (Humira),...
The JAK-STAT Signaling Pathway01:20

The JAK-STAT Signaling Pathway

Several cytokine receptors have tightly bound Janus kinase or JAK proteins attached at their cytosolic tail. Small signaling molecules such as cytokines, growth hormones, or prolactins bind to the cytokine receptors and initiate their dimerization. The dimerization brings the cytosolic JAKs together that trans-phosphorylate and activates each other. The activated JAKs now phosphorylate cytosolic tails of the cytokine receptors, which serve as binding sites for adaptor proteins such as  SH2...
Inflammatory Response01:28

Inflammatory Response

An inflammatory response is a localized, nonspecific immune reaction that occurs when a tissue is injured. It is characterized by redness, swelling, heat, and pain, which are commonly called the cardinal signs and symptoms of inflammation. Inflammation can sometimes result in a loss of function.
Inflammation can be triggered by various stimuli, such as impact, abrasion, chemical irritation, infections, and extreme hot or cold temperatures. These can damage cells and connective tissue fibers,...